in Q2’2018), primarily attributable to an interest income. Share of Profit (Loss) of Associates and Joint Ventures  Share of profit from associates decreased 10.3% y-on-y from Baht 116 million in 6M

each. The Company paid for paid-up share capital, in a portion of 10 percent, in the total amount of Baht 700 million (Baht 350 million each). On June 16, 2017, NBM and EBM have entered into the

million in Q3’2018), primarily attributable to gain from business combination (BGYSP) amount of Baht 276 million which should be amortised by Baht 12 million per annum along the PPA life. Share of Profit

.  Selling expenses Selling expenses for year 2017 and 2016 amounting to THB 185 million and THB 160 million in respectively, with the amount was recorded at the same level.  Administrative expenses

, with the amount was recorded at the same level.  Administrative expenses Administrative expenses for 1st Quarter of 2018 and 2017 amounted to THB 131 million and THB 119 million in respectively, whereby

Company has been awarded ISO 13485, the Quality Management System for Medical Device Industry which is an important tool for competition and maintaining the product’s market share), the Company can maintain

recoverable amount is lower than the carrying amount. In 2018, the consolidated financial statements has recorded loss from impairment of THB 505 million consisting of impairment goodwill (THB 86 million

last year due to long term loan and working capital. (8) Share of profit (loss) from investment in associated company and joint ventures In the third quarter of 2018, the Company recognized the profit

% 0.1% 5.6% 5.6% - Administrative Expense per net sales 10.0% 11.5% (1.5%) 7.8% 8.0% (0.2%) Net profit margin 7.4% 4.0% 3.4% 9.6% 7.3% 2.3% - Basic earnings per share (Bath/Share) 0.08 0.04 0.04 94.7 0.11

, accounting for 8.19% due to the previous year, the retirement financial estimate was recorded from 3 0 0 days to 4 0 0 days. An additional estimate has been made to expenses in the prior year. The lower